申请人:SMITHKLINE BEECHAM CORP
公开号:WO2003104218A1
公开(公告)日:2003-12-18
The present invention provides novel compounds and methods for using them to treat diseases with aminothiophene inhibitors of IKK-ß phosphorylation of I:B. In so doing these aminothiophene inhibitors block pathological activation of transcription factor NF-:B in which diseases excessive activation of NF-:B is implicated.
本发明提供了一种新的化合物和使用它们来治疗使用IKK-ß的氨基噻吩抑制剂对I:B的磷酸化来治疗疾病的方法。通过这种方法,这些氨基噻吩抑制剂阻断了转录因子NF-:B的病理性激活,在这些疾病中,NF-:B的过度激活被认为是其中的原因。